CMS to terminate Medicare Advantage drug contracts with 2 Centene plans

(By Jakob Emerson for Becker’s Hospital Review)

CMS is terminating Centene’s WellCare Medicare Advantage prescription drug plans in Arizona and North Carolina at the end of 2024 following three consecutive years of star ratings below three stars. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org